Skip to main content
. 2016 Dec 20;6:260. doi: 10.3389/fonc.2016.00260

Figure 2.

Figure 2

Recurrence-free survival compared between the two arms using Kaplan–Meier analyses. Group A represents Arm 1 (paclitaxel 15 mg/m2, three times per week), and Group B represents Arm 2 (paclitaxel 45 mg/m2 per week).